Ethyl orthoformate → Tert-butyl 4-(5-bromo-[1,2,4]triazolo[4,3-a]pyrazin-8-yl)piperazine-1-carboxylate
Reaction equation
[Br:1][C:2]1[N:3]=[C:4]([NH:21][NH2:22])[C:5]([N:8]2[CH2:13][CH2:12][N:11]([C:14]([O:16][C:17]([CH3:20])([CH3:19])[CH3:18])=[O:15])[CH2:10][CH2:9]2)=[N:6][CH:7]=1.[CH:23](OCC)(OCC)OCC>>[Br:1][C:2]1[N:3]2[CH:23]=[N:22][N:21]=[C:4]2[C:5]([N:8]2[CH2:9][CH2:10][N:11]([C:14]([O:16][C:17]([CH3:18])([CH3:19])[CH3:20])=[O:15])[CH2:12][CH2:13]2)=[N:6][CH:7]=1Participants
3
Conditions
- Temperature
- 130 °C
Procedure
A 50 mL round bottom flask was charged with tert-butyl 4-(5-bromo-3-hydrazinylpyrazin-2-yl)piperazine-1-carboxylate (5.8 g, 20 mmol) and triethyl orthoformate (60 mL). The resulting solution was heated at 130° C. for 3 h. TLC indicated a complete conversion. The solvent was evaporated and the residue was purified by flash column chromatography on silica gel with 2% methanol in dichloromethane, to afford 5.3 g (69%) of the product as a yellow solid. MS m/z: 383 (M+H+).
Workup
- customThe solvent was evaporated
- customthe residue was purified by flash column chromatography on silica gel with 2% methanol in dichloromethane
Sources & evidence
- ORD record
- ord-c1aace705bb44a5c8bf16752747c1b5c
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08569300B2
Reaction notes
Loading…